Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.09 USD | -6.08% | -12.22% | +52.97% |
10/05 | Leerink Partners Starts Aquestive Therapeutics With Outperform Rating, $8 Price Target | MT |
08/05 | Transcript : Aquestive Therapeutics, Inc., Q1 2024 Earnings Call, May 08, 2024 |
- Stock Market
- Equities
- AQST Stock
- News Aquestive Therapeutics, Inc.
- MarketScreener Strategies